Publications by authors named "Roger Sarduy"

Claim this Profile
M
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis.
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau

J Am Heart Assoc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.
Geneviève Frégeau, Roger Sarduy, Hanan Elimam, Cloé L Esposito, Katia Mellal

Atherosclerosis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.
Victor Brito, Katia Mellal, Karina F Zoccal, Yosdel Soto, Liliane Ménard, Roger Sarduy

Front Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE Mice: Association with Atheroprotection.
Roger Sarduy, Victor Brito, Adriana Castillo, Yosdel Soto, Tania Griñán

Front Immunol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis